학술논문
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial
Document Type
Article
Author
Source
In: The Lancet Haematology . (The Lancet Haematology, February 2022, 9(2):e121-e132)
Subject
Language
English
ISSN
23523026